For American patients aching for relief from the sky-high price of drugs, the news has been decidedly mixed recently.
“It’s unacceptable that Americans pay vastly more than people in other countries for the exact same drugs, often made in the exact same place. This is wrong, this is unfair, and together we will stop it—and we’ll stop it fast,” President Donald Trump vowed in his State of the Union address on February 5.
Six days later, Sanofi and Regeneron Pharmaceuticals . . .